GetTopicDetailResponse(id=5c2a3035026, topicName=內(nèi)分泌紊亂, introduction=內(nèi)分泌紊亂, content=null, image=null, comments=4, allHits=1241, url=https://h5.medsci.cn/topic?id=30350, type=0, isShow=1, status=1, isAdmin=null, adminId=1, adminEncryptionId=1eae1, adminName=小M, createdBy=null, createdName=, createdAvatar=, createdTime=Fri May 29 21:19:53 CST 2020, time=2020-05-29, bannerImg=https://img.medsci.cn/202167/1623032167418_5160405.png, bannerImgH5=https://img.medsci.cn/202167/1623032167418_5160405.png, likes=0, followStatus=false, moduleDTOList=null, tagId=34757, tagList=[TagDto(tagId=34757, tagName=內(nèi)分泌紊亂)], ipAttribution=, topicAdmin=1, lengthMark=0)
[GetTopicListResponse(id=2126257, encodeId=1847212625e0a, content=<a href='/topic/show?id=0de5290588c' target=_blank style='color:#2F92EE;'>#免疫檢查點(diǎn)抑制劑#</a>和<a href='/topic/show?id=5c2a3035026' target=_blank style='color:#2F92EE;'>#內(nèi)分泌紊亂#</a>, objectTitle=2022 韓國(guó)內(nèi)分泌學(xué)會(huì)的立場(chǎng)聲明：免疫檢查點(diǎn)抑制劑和內(nèi)分泌紊亂, objectType=guider, longId=21751, objectId=32dd31c00291129f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/guideline/show_article.do?id=32dd31c00291129f, replyNumber=0, likeNumber=108, createdTime=2023-04-16, rootId=0, userName=俠膽醫(yī)心, userId=f63e4754896, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=香港, moduleDTOList=[ModuleDTO(moduleId=32dd31c00291129f, moduleTitle=2022 韓國(guó)內(nèi)分泌學(xué)會(huì)的立場(chǎng)聲明：免疫檢查點(diǎn)抑制劑和內(nèi)分泌紊亂, moduleType=guider, hrefUrl=http://ermita.cn/guideline/show_article.do?id=32dd31c00291129f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2027657, encodeId=24c6202e6579e, content=<a href='/topic/show?id=5c2a3035026' target=_blank style='color:#2F92EE;'>#內(nèi)分泌紊亂#</a>, objectTitle=JCO：全國(guó)、多中心研究：兒童腦腫瘤患者治療后早期內(nèi)分泌紊亂的流行率和危險(xiǎn)因素評(píng)估, objectType=article, longId=82385, objectId=e92b82385d1, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e92b82385d1, replyNumber=0, likeNumber=136, createdTime=2017-01-23, rootId=0, userName=柳葉一刀, userId=778d36, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e92b82385d1, moduleTitle=JCO：全國(guó)、多中心研究：兒童腦腫瘤患者治療后早期內(nèi)分泌紊亂的流行率和危險(xiǎn)因素評(píng)估, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=e92b82385d1)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2027656, encodeId=eab6202e65609, content=<a href='/topic/show?id=5c2a3035026' target=_blank style='color:#2F92EE;'>#內(nèi)分泌紊亂#</a>, objectTitle=Clin Endocrinol：HIV感染女性存在內(nèi)分泌紊亂？, objectType=article, longId=69075, objectId=1508690e5f8, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1508690e5f8, replyNumber=0, likeNumber=85, createdTime=2017-04-11, rootId=0, userName=柳葉一刀, userId=778d36, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1508690e5f8, moduleTitle=Clin Endocrinol：HIV感染女性存在內(nèi)分泌紊亂？, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=1508690e5f8)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2027655, encodeId=cb3a202e6551c, content=<a href='/topic/show?id=5c2a3035026' target=_blank style='color:#2F92EE;'>#內(nèi)分泌紊亂#</a>, objectTitle=Lancet：兒童癌癥幸存者內(nèi)分泌紊亂風(fēng)險(xiǎn)增加, objectType=article, longId=31601, objectId=a3d4316016e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a3d4316016e, replyNumber=0, likeNumber=80, createdTime=2014-06-02, rootId=0, userName=柳葉一刀, userId=778d36, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a3d4316016e, moduleTitle=Lancet：兒童癌癥幸存者內(nèi)分泌紊亂風(fēng)險(xiǎn)增加, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=a3d4316016e)], followStatus=false, userIsMember=false, type=1, lengthMark=0)]
梅斯話題小助手
2020-05-29
